Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Maxime Dely: Sickle Cell Disease – Behind Every Exchange, There Is a Donor
Maxime Dely/ LinkedIn
Aug 22, 2026, 17:26

Maxime Dely: Sickle Cell Disease – Behind Every Exchange, There Is a Donor

Maxime Dely, Therapeutic Solutions Sales Consultant at Terumo Blood and Cell Technologies, shared a post on LinkedIn:

“Sickle cell disease: Behind every exchange, there is a donor.

Sickle cell disease sometimes requires automated red blood cell exchange, an impressive technology that helps reduce hemoglobin S and improve patient care.

But this technology depends on one essential resource: compatible blood.

Repeated transfusions carry a risk of alloimmunization when transfused red blood cells carry antigens that differ from those of the patient.

This is why specific blood phenotypes are required.

Yet these blood profiles are now particularly rare in blood supplies.

As a result, an exchange that would ideally require 6 red blood cell units may sometimes have to be performed with 5 or 4, potentially reducing its effectiveness and requiring more frequent procedures.

Access to automated apheresis is a major medical advance. But without compatible blood, it cannot reach its full potential.

So let’s mobilize: donate blood and help raise awareness of this critical need.

Behind every blood unit, there is a donor, a patient, and the possibility of receiving the treatment they need.

Donating blood can make treatment possible.”

Maxime Dely: Sickle Cell Disease - Behind Every Exchange, There Is a Donor

Other posts featuring Maxime Dely on Hemostasis Today.

Alloimmunization Blood Blood donation Hematology Hemoglobin S Hemostasis Hemostasis News Hemostasis Today Medicine Sickle Cell Disease Transfusion Medicine
NewsFeed